Pfizer R&D staff braces for layoffs

Pharmalot has been piecing together the likely fallout from Pfizer's move to restructure its R&D system.  Sources are telling Pharmalot that layoffs will be "substantial," though there's no direct word on just what kind of numbers are to be expected.  Pfizer report